Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Hepatitis C Virus (HCV) Treatment Completion or Withdrawal

This study has been completed.
Information provided by (Responsible Party):
VA Office of Research and Development Identifier:
First received: May 6, 2008
Last updated: April 27, 2015
Last verified: April 2015
Qualitative pilot study of patients' views of their experience with antiviral treatment for hepatitis C.

Hepatitis C

Study Type: Observational
Study Design: Time Perspective: Retrospective
Official Title: Patients' View of Hepatitis C Treatment Completion or Withdrawal

Resource links provided by NLM:

Further study details as provided by VA Office of Research and Development:

Primary Outcome Measures:
  • Attributes of Treatment Experience [ Time Frame: Zero to five years since ending treatment. ]
    Four basic reasons for persisting in antiviral treatment were identified: cure the disease, concern about diminishing time to act (avoid bad end), demonstation of personal strength, and redemption for past behavior.

Enrollment: 21
Study Start Date: May 2008
Study Completion Date: August 2008
Primary Completion Date: August 2008 (Final data collection date for primary outcome measure)
Hepatitis C patients
patients who initiated antiviral treatment for hepatitis C

Detailed Description:
Qualitative pilot study of patient' views of their experiences with antiviral treatment for hepatitis C. Two groups of patients will be sampled: nine who completed a 24 or 48 week course of treatment and nine who withdrew from treatment prior to planned end. Interview data will be analyzed using narrative and grounded theory methods to identify attributes of treatment experience that may discriminate between completion and withdrawal.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
VHA patients who ever initiated antiviral treatment for hepatitis C.

Inclusion Criteria:

Ever initiated anitiviral treatment for hepatitis C.

Exclusion Criteria:

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00674492

United States, Massachusetts
Edith Nourse Rogers Memorial Veterans Hospital, Bedford, MA
Bedford, Massachusetts, United States, 01730
Sponsors and Collaborators
VA Office of Research and Development
Principal Investigator: Jack A Clark, PhD Edith Nourse Rogers Memorial Veterans Hospital, Bedford, MA
  More Information

Responsible Party: VA Office of Research and Development Identifier: NCT00674492     History of Changes
Other Study ID Numbers: SHP 08-193
Study First Received: May 6, 2008
Results First Received: February 5, 2015
Last Updated: April 27, 2015

Additional relevant MeSH terms:
Hepatitis A
Hepatitis C
Liver Diseases
Digestive System Diseases
Hepatitis, Viral, Human
Virus Diseases
Enterovirus Infections
Picornaviridae Infections
RNA Virus Infections
Flaviviridae Infections processed this record on May 25, 2017